Approaches for the discovery of new cell-penetrating peptides

被引:25
|
作者
Porosk, Ly [1 ]
Gaidutsik, Ilja [1 ]
Langel, Ulo [2 ]
机构
[1] Univ Tartu, Inst Technol, EE-50411 Tartu, Estonia
[2] Stockholm Univ, Dept Biochem & Biophys, Stockholm, Sweden
关键词
CPP; HTS; PTD; delivery vectors; CPP prediction; IN-VITRO; PREDICTION; SEQUENCE; NANOPARTICLES; BRAIN;
D O I
10.1080/17460441.2021.1851187
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Introduction: The capability of cell-penetrating peptides (CPP), also known as protein transduction domains (PTD), to enter into cells possibly with an attached cargo, makes their application as delivery vectors or as direct therapeutics compelling. They are generally biocompatible, nontoxic, and easy to synthesize and modify. Three decades after the discovery of the first CPPs, similar to 2,000 CPP sequences have been identified, and many more predicted. Nevertheless, the field has a strong commitment to authenticate new, more efficient, and specific CPPs. Areas covered: Although a scattering of CPPs have been found by chance, various systematic approaches have been developed and refined over the years to directly aid the identification and depiction of new peptide-based delivery vectors or therapeutics. Here, the authors give an overview of CPPs, and review various approaches of discovering new ones. An emphasis is placed on in silico methods, as these have advanced rapidly in recent years. Expert opinion: Although there are many known CPPs, there is a need to find more efficient and specific CPPs. Several approaches are used to identify such sequences. The success of these approaches depends on the advancement of others and the successful prediction of CPP sequences relies on experimental data.
引用
收藏
页码:553 / 565
页数:13
相关论文
共 50 条
  • [21] Interaction of nanoparticles and cell-penetrating peptides with skin for transdermal drug delivery
    Desai, Pinaki
    Patlolla, Ram R.
    Singh, Mandip
    MOLECULAR MEMBRANE BIOLOGY, 2010, 27 (07) : 247 - 259
  • [22] Status update in the use of cell-penetrating peptides for the delivery of macromolecular therapeutics
    Kurrikoff, Kaido
    Vunk, Birgit
    Langel, Ulo
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2021, 21 (03) : 361 - 370
  • [23] Ocular Delivery of Therapeutic Agents by Cell-Penetrating Peptides
    Nhan, Nguyen Thi Thanh
    Maidana, Daniel E.
    Yamada, Kaori H.
    CELLS, 2023, 12 (07)
  • [24] An update on cell-penetrating peptides with intracellular organelle targeting
    Cerrato, Carmine Pasquale
    Langel, Ulo
    EXPERT OPINION ON DRUG DELIVERY, 2022, 19 (02) : 133 - 146
  • [25] Translocation of cell-penetrating peptides into Candida fungal pathogens
    Gong, Zifan
    Karlsson, Amy J.
    PROTEIN SCIENCE, 2017, 26 (09) : 1714 - 1725
  • [26] Cell-Penetrating Peptides: Applications in Tumor Diagnosis and Therapeutics
    Stiltner, Jeffrey
    McCandless, Kayla
    Zahid, Maliha
    PHARMACEUTICS, 2021, 13 (06)
  • [27] Chemical-Functional Diversity in Cell-Penetrating Peptides
    Stalmans, Sofie
    Wynendaele, Evelien
    Bracke, Nathalie
    Gevaert, Bert
    D'Hondt, Matthias
    Peremans, Kathelijne
    Burvenich, Christian
    De Spiegeleer, Bart
    PLOS ONE, 2013, 8 (08):
  • [28] Nα-Methylation of arginine: Implications for cell-penetrating peptides
    Calabretta, Lindsey O.
    Yang, Jinyi
    Raines, Ronald T.
    JOURNAL OF PEPTIDE SCIENCE, 2023, 29 (05)
  • [29] Effect of cell-penetrating peptides on the nasal absorption of insulin
    Khafagy, El-Sayed
    Morishita, Mariko
    Isowa, Koichi
    Imai, Jun
    Takayama, Kozo
    JOURNAL OF CONTROLLED RELEASE, 2009, 133 (02) : 103 - 108
  • [30] Transduction of adenovirus vectors modified with cell-penetrating peptides
    Eto, Yusuke
    Yoshioka, Yasuo
    Asavatanabodee, Ratima
    Kida, Shinya
    Maeda, Mitsuko
    Mukai, Yohei
    Mizuguchi, Hiroyuki
    Kawasaki, Koichi
    Okada, Naoki
    Nakagawa, Shinsaku
    PEPTIDES, 2009, 30 (08) : 1548 - 1552